当前位置:首页 - 行情中心 - 智飞生物(300122) - 财务分析 - 现金流量表

智飞生物

(300122)

  

流通市值:195.88亿  总市值:331.54亿
流通股本:14.14亿   总股本:23.94亿

现金流量表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金7,963,919,746.294,877,325,0042,053,435,486.3214,680,558,384.83
  收到的税费返还3,684,645.651,762,966.61,546,975.24406,133.03
  收到其他与经营活动有关的现金169,673,315.89131,728,874.63103,102,357.04348,560,940.09
  经营活动现金流入小计8,137,277,707.835,010,816,845.232,158,084,818.615,029,525,457.95
  购买商品、接受劳务支付的现金1,792,048,7101,318,928,257.41930,076,569.085,467,257,130.06
  支付给职工以及为职工支付的现金1,305,376,660.54918,021,013.85538,908,087.641,785,937,410.71
  支付的各项税费174,758,059.59167,101,408.89103,402,756.77444,345,468.94
  支付其他与经营活动有关的现金946,488,379.1632,423,012.63307,628,110.32,164,665,764.55
  经营活动现金流出小计4,218,671,809.233,036,473,692.781,880,015,523.799,862,205,774.26
  经营活动产生的现金流量净额3,918,605,898.61,974,343,152.45278,069,294.815,167,319,683.69
二、投资活动产生的现金流量:
  收回投资收到的现金---5,650,000
  处置固定资产、无形资产和其他长期资产收回的现金净额59,43024,93020,0006,941,779.9
  收到的其他与投资活动有关的现金---76,653,395.92
  投资活动现金流入小计59,43024,93020,00089,245,175.82
  购建固定资产、无形资产和其他长期资产支付的现金294,313,022.6199,803,879.07102,111,213.21619,186,865.2
  投资支付的现金16,643,221.4416,643,221.44--
  支付其他与投资活动有关的现金---65,000,000
  投资活动现金流出小计310,956,244.04216,447,100.51102,111,213.21684,186,865.2
  投资活动产生的现金流量净额-310,896,814.04-216,422,170.51-102,091,213.21-594,941,689.38
三、筹资活动产生的现金流量:
  取得借款收到的现金8,020,591,225.377,999,713,375.147,985,500,00013,347,907,154.56
  收到其他与筹资活动有关的现金120,279,928.3179,709,090.34217,1765,543,763.98
  筹资活动现金流入小计8,140,871,153.688,079,422,465.487,985,717,17613,353,450,918.54
  偿还债务支付的现金11,633,065,956.3110,069,210,295.318,937,782,848.4717,640,883,864.41
  分配股利、利润或偿付利息支付的现金289,613,625.79199,648,376.1115,158,049.99344,806,186.96
  支付其他与筹资活动有关的现金750,673,813.15206,773,342.518,026,977.82100,560,885.36
  筹资活动现金流出小计12,673,353,395.2510,475,632,013.929,060,967,876.2818,086,250,936.73
  筹资活动产生的现金流量净额-4,532,482,241.57-2,396,209,548.44-1,075,250,700.28-4,732,800,018.19
四、汇率变动对现金及现金等价物的影响-665,297.11-475,442.49-16,911,711.49-687,237.77
五、现金及现金等价物净增加额-925,438,454.12-638,764,008.99-916,184,330.17-161,109,261.65
  加:期初现金及现金等价物余额2,542,960,105.312,542,960,105.312,542,960,105.312,704,069,366.96
  期末现金及现金等价物余额1,617,521,651.191,904,196,096.321,626,775,775.142,542,960,105.31
补充资料:
  净利润--820,337,587.68--14,745,264,578.46
  资产减值准备--190,587,294.03-14,128,158,835.41
  固定资产和投资性房地产折旧-238,660,178.62-454,483,762.7
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-238,660,178.62-454,483,762.7
  无形资产摊销-27,586,205.96-47,638,923.69
  长期待摊费用摊销-12,203,428.47-19,171,476.87
  处置固定资产、无形资产和其他长期资产的损失--3,107.74--5,880,932.83
  固定资产报废损失-87,311.67-377,197.29
  公允价值变动损失---14,221,154.72
  财务费用-165,876,173.11-320,216,154.03
  投资损失-2,314,595.19--13,903.16
  递延所得税--198,989,539.68--2,739,062,471.7
  其中:递延所得税资产减少--194,431,222.84--2,730,416,491.8
    递延所得税负债增加--4,558,316.84--8,645,979.9
  存货的减少-2,790,924,647.2-3,621,815,564.67
  经营性应收项目的减少-304,260,315.31-4,906,833,752.15
  经营性应付项目的增加--721,758,644.02--868,543,909.5
  现金的期末余额-1,904,196,096.32-2,542,960,105.31
  减:现金的期初余额-2,542,960,105.31-2,704,069,366.96
  现金及现金等价物的净增加额--638,764,008.99--161,109,261.65
公告日期2026-10-272026-08-292026-04-282026-04-28
审计意见(境内)标准无保留意见
TOP↑